NCT02169271View on ClinicalTrials.gov

Acetylsalicylic Acid Compared to Placebo in Treating High-Risk Patients With Subsolid Lung Nodules

PHASE2CompletedINTERVENTIONAL
Enrollment

109

Participants

Timeline

Start Date

November 21, 2014

Primary Completion Date

July 13, 2018

Study Completion Date

February 14, 2020

Conditions
Current SmokerFormer SmokerMultiple Pulmonary NodulesTobacco Use Disorder
Interventions
DRUG

Aspirin

Given PO

OTHER

Laboratory Biomarker Analysis

Correlative studies

OTHER

Placebo

Given PO

Trial Locations (2)

20141

European Institute of Oncology, Milan

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT02169271 - Acetylsalicylic Acid Compared to Placebo in Treating High-Risk Patients With Subsolid Lung Nodules | Biotech Hunter | Biotech Hunter